Backed by an initial funding of $15 million from the National Science Foundation, the Regenerative Medicine Engine is the ...

Three young Triangle-based medical technology companies with roots in Duke University research labs are getting major global attention from their industry. They’re among the 65 cutting-edge companies ...

The U.S. stock market is expected to remain volatile due to rising inflation pressures fueled by new tariffs and uncertainty around corporate earnings. In this context, creating a curated portfolio of ...

Analysts are lukewarm on Merck, giving it a “Hold” consensus with a $108.69 price target despite some bullish and bearish ...